LLY's Options Signal High Conviction at $900 Calls Amid Bullish Fundamentals: Here's How to Play the Breakout

Generated by AI AgentOptions FocusReviewed byTianhao Xu
Wednesday, Oct 22, 2025 4:49 pm ET2min read
LLY--
  • Eli LillyLLY-- (LLY) surged 1.4% to $810.97, trading above its 30D and 200D moving averages.
  • RSI at 40.8 hints at oversold conditions, while call open interest spikes at $900 and $1000 strikes.
  • Three major news catalysts—breast cancer drug success, diabetes trial wins, and new lab openings—could fuel further upside.
  • The big takeaway: Options data and fundamentals align for a potential breakout above $815.57, with $900 calls as a high-conviction play.

What the Options Chain Reveals About Market Sentiment

Let’s start with the numbers that scream conviction. The options market is loaded with call open interest at the $900 (5,823 contracts) and $1,000 (2,573) strikes for Friday expiration. That’s not just noise—it’s a bet that LLYLLY-- will punch through its intraday high of $815.57 and keep climbing. Meanwhile, puts at $770 (896 contracts) and $760 (834) show some downside hedging, but the put/call ratio of 0.84 (favoring calls) suggests bulls are in control.

The absence of block trades is telling too. No whale-sized trades to exploit here—just retail and institutional players stacking up calls at those key levels. If you’re a trader, this is a green light to focus on upside setups. The risk? A breakdown below $793.82 (intraday low) could trigger panic, but the 30D support at $754–$756.82 is still a long way off.

Why the News Flow Matches the Options Buzz

Now, let’s connect the dots between the options frenzy and the headlines. Eli Lilly’s Verzenio showing a 15% reduction in breast cancer mortality isn’t just a medical win—it’s a revenue catalyst. Add that to the diabetes drug orforglipron hitting its primary endpoint and the new San Diego lab boosting R&D, and you’ve got a triple threat for earnings growth.

Here’s the kicker: Investors are pricing in these wins. The $900 and $1,000 call strikes aren’t just speculative—they’re bets on LLY’sLLY-- ability to sustain momentum through Q3 2025 earnings. The RSI at 40.8 isn’t a red flag; it’s a green light for a rebound. If the stock holds above $803.40 (middle Bollinger Band), the path to $892.19 (upper band) looks increasingly probable.

Actionable Trade Ideas for LLY: Calls, Puts, and Price Levels

Let’s get tactical. For options players, the $900 calls expiring Friday (OI: 5,823) are the most compelling. If LLY breaks above $815.57 (intraday high), these strikes could see explosive gamma. For a safer play, the $820 calls (OI: 701) offer leverage if the stock consolidates near $803.40.

On the stock side, here’s a concrete setup:

  • Entry: Buy LLY near $803.40 if it holds above the middle Bollinger Band.
  • Stop Loss: Below $793.82 (intraday low).
  • Target: Aim for $892.19 (upper Bollinger Band) as a high-probability resistance level.

For downside protection, consider selling the $770 puts expiring next Friday (OI: 685). They’re cheap but could hedge against a sudden dip if the RSI fails to recover.

Volatility on the Horizon: What to Watch

The next 30 days will be critical. LLY’s Q3 2025 earnings call and the ESMO conference in October could amplify the current momentum. If the stock holds above $786.75 (200D MA), the long-term ranging pattern could shift into a bullish trend. But don’t ignore the risks: A drop below $764.19 (100D MA) would invalidate the current setup.

In short, LLY is at a crossroads. The options market is pricing in a breakout, the fundamentals are firing on all cylinders, and technicals suggest a low-risk entry. For traders, this is a rare alignment of factors—capitalize on it before the next wave of news hits.

Final Takeaway

Eli Lilly’s options activity and news flow paint a clear picture: bulls are in control, and the stock is primed for a move. Whether you’re buying calls at $900 or playing the stock’s support at $803.40, the key is to act before the broader market catches up. Keep an eye on the 200D MA as a psychological floor, and don’t let a minor pullback cloud the bigger picture. This is a stock with momentum—and momentum, when backed by fundamentals, can carry you far.

Focus on daily option trades

Latest Articles

Unlock Market-Moving Insights.

Subscribe to PRO Articles.

  • AI-Driven Trading Signals - 24/7 Market Opportunities.
  • Ultra-Timely & Actionable - Translate events directly into clear portfolio strategies.
  • Diverse Assets Coverage - Options, 0DTE, ETFs, and Cryptos.
  • Get 7-Day FREE Pro Articles - Sign Up Now

    Learn more

    Already have an account?

    Unlock Market-Moving Insights.

    Subscribe to PRO Articles.

  • AI-Driven Trading Signals - 24/7 Market Opportunities.
  • Ultra-Timely & Actionable - Translate events directly into clear portfolio strategies.
  • Diverse Assets Coverage - Options, 0DTE, ETFs, and Cryptos.
  • Get 7-Day FREE Pro Articles - Sign Up Now

    Learn more

    Already have an account?

    Stay ahead of the market.

    Get curated U.S. market news, insights and key dates delivered to your inbox.